Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2016 | Pages:
1645 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Colorectal Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Colorectal Cancer - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Colorectal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. The Colorectal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colorectal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 26, 106, 110, 9, 145, 36 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 15, 8, 22 and 3 molecules, respectively. Colorectal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data. Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Colorectal Cancer (Oncology). - The pipeline guide reviews pipeline therapeutics for Colorectal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology) Reasons To Buy - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies. - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage. - Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology). - Classify potential new clients or partners in the target demographic. - Develop tactical initiatives by understanding the focus areas of leading companies. - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics. - Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
Table of Contents 2 Introduction 12 Colorectal Cancer Overview 13 Therapeutics Development 14 Colorectal Cancer - Therapeutics under Development by Companies 16 Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes 36 Colorectal Cancer - Pipeline Products Glance 38 Colorectal Cancer - Products under Development by Companies 42 Colorectal Cancer - Products under Investigation by Universities/Institutes 71 Colorectal Cancer - Companies Involved in Therapeutics Development 74 Colorectal Cancer - Therapeutics Assessment 312 Drug Profiles 359 Colorectal Cancer - Dormant Projects 1545 Colorectal Cancer - Discontinued Products 1576 Colorectal Cancer - Product Development Milestones 1584 Appendix 1593
List of Tables
Number of Products under Development for Colorectal Cancer, H2 2016 65 Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2016 66 Number of Products under Development by Companies, H2 2016 68 Number of Products under Development by Companies, H2 2016 (Contd..1) 69 Number of Products under Development by Companies, H2 2016 (Contd..2) 70 Number of Products under Development by Companies, H2 2016 (Contd..3) 71 Number of Products under Development by Companies, H2 2016 (Contd..4) 72 Number of Products under Development by Companies, H2 2016 (Contd..5) 73 Number of Products under Development by Companies, H2 2016 (Contd..6) 74 Number of Products under Development by Companies, H2 2016 (Contd..7) 75 Number of Products under Development by Companies, H2 2016 (Contd..8) 76 Number of Products under Development by Companies, H2 2016 (Contd..9) 77 Number of Products under Development by Companies, H2 2016 (Contd..10) 78 Number of Products under Development by Companies, H2 2016 (Contd..11) 79 Number of Products under Development by Companies, H2 2016 (Contd..12) 80 Number of Products under Development by Companies, H2 2016 (Contd..13) 81 Number of Products under Development by Companies, H2 2016 (Contd..14) 82 Number of Products under Development by Companies, H2 2016 (Contd..15) 83 Number of Products under Development by Companies, H2 2016 (Contd..16) 84 Number of Products under Development by Companies, H2 2016 (Contd..17) 85 Number of Products under Development by Companies, H2 2016 (Contd..18) 86 Number of Products under Investigation by Universities/Institutes, H2 2016 87 Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 88 Comparative Analysis by Late Stage Development, H2 2016 89 Comparative Analysis by Clinical Stage Development, H2 2016 90 Comparative Analysis by Early Stage Development, H2 2016 91 Comparative Analysis by Unknown Stage Development, H2 2016 92 Products under Development by Companies, H2 2016 93 Products under Development by Companies, H2 2016 (Contd..1) 94 Products under Development by Companies, H2 2016 (Contd..2) 95 Products under Development by Companies, H2 2016 (Contd..3) 96 Products under Development by Companies, H2 2016 (Contd..4) 97 Products under Development by Companies, H2 2016 (Contd..5) 98 Products under Development by Companies, H2 2016 (Contd..6) 99 Products under Development by Companies, H2 2016 (Contd..7) 100 Products under Development by Companies, H2 2016 (Contd..8) 101 Products under Development by Companies, H2 2016 (Contd..9) 102 Products under Development by Companies, H2 2016 (Contd..10) 103 Products under Development by Companies, H2 2016 (Contd..11) 104 Products under Development by Companies, H2 2016 (Contd..12) 105 Products under Development by Companies, H2 2016 (Contd..13) 106 Products under Development by Companies, H2 2016 (Contd..14) 107 Products under Development by Companies, H2 2016 (Contd..15) 108 Products under Development by Companies, H2 2016 (Contd..16) 109 Products under Development by Companies, H2 2016 (Contd..17) 110 Products under Development by Companies, H2 2016 (Contd..18) 111 Products under Development by Companies, H2 2016 (Contd..19) 112 Products under Development by Companies, H2 2016 (Contd..20) 113 Products under Development by Companies, H2 2016 (Contd..21) 114 Products under Development by Companies, H2 2016 (Contd..22) 115 Products under Development by Companies, H2 2016 (Contd..23) 116 Products under Development by Companies, H2 2016 (Contd..24) 117 Products under Development by Companies, H2 2016 (Contd..25) 118 Products under Development by Companies, H2 2016 (Contd..26) 119 Products under Development by Companies, H2 2016 (Contd..27) 120 Products under Development by Companies, H2 2016 (Contd..28) 121 Products under Investigation by Universities/Institutes, H2 2016 122 Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 123 Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 124 Colorectal Cancer - Pipeline by 2cureX ApS, H2 2016 125 Colorectal Cancer - Pipeline by 3-V Biosciences Inc, H2 2016 126 Colorectal Cancer - Pipeline by 3M Drug Delivery Systems, H2 2016 127 Colorectal Cancer - Pipeline by 3SBio Inc, H2 2016 128 Colorectal Cancer - Pipeline by 4SC AG, H2 2016 129 Colorectal Cancer - Pipeline by AB Science SA, H2 2016 130 Colorectal Cancer - Pipeline by AbbVie Inc, H2 2016 131 Colorectal Cancer - Pipeline by AbGenomics International Inc, H2 2016 132 Colorectal Cancer - Pipeline by Accelerated Pharma Inc, H2 2016 133 Colorectal Cancer - Pipeline by Adamed Sp z oo, H2 2016 134 Colorectal Cancer - Pipeline by Aduro BioTech Inc, H2 2016 135 Colorectal Cancer - Pipeline by Advenchen Laboratories LLC, H2 2016 136 Colorectal Cancer - Pipeline by Alchemia Ltd, H2 2016 137 Colorectal Cancer - Pipeline by Allinky Biopharma, H2 2016 138 Colorectal Cancer - Pipeline by Amal Therapeutics SA, H2 2016 139 Colorectal Cancer - Pipeline by amcure GmbH, H2 2016 140 Colorectal Cancer - Pipeline by Amgen Inc, H2 2016 141 Colorectal Cancer - Pipeline by Antibe Therapeutics Inc, H2 2016 142 Colorectal Cancer - Pipeline by Apac Biotech Pvt Ltd, H2 2016 143 Colorectal Cancer - Pipeline by Apexigen Inc, H2 2016 144 Colorectal Cancer - Pipeline by Aphios Corp, H2 2016 145 Colorectal Cancer - Pipeline by Aposense Ltd, H2 2016 146 Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals Inc, H2 2016 147 Colorectal Cancer - Pipeline by ARMO Biosciences Inc, H2 2016 148 Colorectal Cancer - Pipeline by ArQule Inc, H2 2016 149 Colorectal Cancer - Pipeline by Array BioPharma Inc, H2 2016 150 Colorectal Cancer - Pipeline by Asana BioSciences LLC, H2 2016 151 Colorectal Cancer - Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2016 152 Colorectal Cancer - Pipeline by Astellas Pharma Inc, H2 2016 153 Colorectal Cancer - Pipeline by Astex Pharmaceuticals Inc, H2 2016 154 Colorectal Cancer - Pipeline by AstraZeneca Plc, H2 2016 155 Colorectal Cancer - Pipeline by ATLAB Pharma SAS, H2 2016 156 Colorectal Cancer - Pipeline by AVEO Pharmaceuticals Inc, H2 2016 157 Colorectal Cancer - Pipeline by B Cell Design SAS, H2 2016 158 Colorectal Cancer - Pipeline by Basilea Pharmaceutica Ltd, H2 2016 159 Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2016 160 Colorectal Cancer - Pipeline by Bayer AG, H2 2016 161 Colorectal Cancer - Pipeline by BeiGene Ltd, H2 2016 162 Colorectal Cancer - Pipeline by BeyondSpring Pharmaceuticals Inc, H2 2016 163 Colorectal Cancer - Pipeline by Biocon Ltd, H2 2016 164 Colorectal Cancer - Pipeline by Bionomics Ltd, H2 2016 165 Colorectal Cancer - Pipeline by Bionovis SA, H2 2016 166 Colorectal Cancer - Pipeline by Biotecnol Ltd, H2 2016 167 Colorectal Cancer - Pipeline by Biothera Pharmaceutical Inc, H2 2016 168 Colorectal Cancer - Pipeline by Boehringer Ingelheim GmbH, H2 2016 169 Colorectal Cancer - Pipeline by Boston Biomedical Inc, H2 2016 170 Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2016 171 Colorectal Cancer - Pipeline by Burzynski Research Institute Inc, H2 2016 172 Colorectal Cancer - Pipeline by Calithera Biosciences Inc, H2 2016 173 Colorectal Cancer - Pipeline by Cancer Prevention Pharmaceuticals Inc, H2 2016 174 Colorectal Cancer - Pipeline by Carna Biosciences Inc, H2 2016 175 Colorectal Cancer - Pipeline by Cascadian Therapeutics Inc, H2 2016 176 Colorectal Cancer - Pipeline by CBT Pharmaceuticals Inc, H2 2016 177 Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2016 178 Colorectal Cancer - Pipeline by Celgene Corp, H2 2016 179 Colorectal Cancer - Pipeline by Cellceutix Corp, H2 2016 180 Colorectal Cancer - Pipeline by Celldex Therapeutics Inc, H2 2016 181 Colorectal Cancer - Pipeline by Cellectar Biosciences Inc, H2 2016 182 Colorectal Cancer - Pipeline by Celltrion Inc, H2 2016 183 Colorectal Cancer - Pipeline by Celyad SA, H2 2016 184 Colorectal Cancer - Pipeline by Chiome Bioscience Inc, H2 2016 185 Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2016 186 Colorectal Cancer - Pipeline by ChoDang Pharm Co Ltd, H2 2016 187 Colorectal Cancer - Pipeline by Cipla Ltd, H2 2016 188 Colorectal Cancer - Pipeline by Cleave Biosciences Inc, H2 2016 189 Colorectal Cancer - Pipeline by Cleveland BioLabs Inc, H2 2016 190 Colorectal Cancer - Pipeline by COARE Biotechnology Inc, H2 2016 191 Colorectal Cancer - Pipeline by Coherus BioSciences Inc, H2 2016 192 Colorectal Cancer - Pipeline by Compugen Ltd, H2 2016 193 Colorectal Cancer - Pipeline by Cornerstone Pharmaceuticals Inc, H2 2016 194 Colorectal Cancer - Pipeline by Corvus Pharmaceuticals Inc, H2 2016 195 Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc, H2 2016 196 Colorectal Cancer - Pipeline by CrystalGenomics Inc, H2 2016 197 Colorectal Cancer - Pipeline by Cytune Pharma SAS, H2 2016 198 Colorectal Cancer - Pipeline by Daiichi Sankyo Company Ltd, H2 2016 199 Colorectal Cancer - Pipeline by DanDrit Biotech A/S, H2 2016 200 Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals LLC, H2 2016 201 Colorectal Cancer - Pipeline by Dicerna Pharmaceuticals Inc, H2 2016 202 Colorectal Cancer - Pipeline by Double Bond Pharmaceutical International AB, H2 2016 203 Colorectal Cancer - Pipeline by Dr. Reddy's Laboratories Ltd, H2 2016 204 Colorectal Cancer - Pipeline by EirGenix Inc, H2 2016 205 Colorectal Cancer - Pipeline by Eisai Co Ltd, H2 2016 206 Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2016 207 Colorectal Cancer - Pipeline by Endor Nanotechnologies SL, H2 2016 208 Colorectal Cancer - Pipeline by enGene Inc, H2 2016 209 Colorectal Cancer - Pipeline by EnGeneIC Ltd, H2 2016 210 Colorectal Cancer - Pipeline by Ensol Biosciences Inc, H2 2016 211 Colorectal Cancer - Pipeline by EntreChem SL, H2 2016 212 Colorectal Cancer - Pipeline by Enzo Biochem Inc, H2 2016 213 Colorectal Cancer - Pipeline by Etubics Corp, H2 2016 214 Colorectal Cancer - Pipeline by Exelixis Inc, H2 2016 215 Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd, H2 2016 216 Colorectal Cancer - Pipeline by Five Prime Therapeutics Inc, H2 2016 217 Colorectal Cancer - Pipeline by Formosa Laboratories Inc, H2 2016 218 Colorectal Cancer - Pipeline by Gene Techno Science Co Ltd, H2 2016 220 Colorectal Cancer - Pipeline by Genentech Inc, H2 2016 221 Colorectal Cancer - Pipeline by Genor BioPharma Co Ltd, H2 2016 222 Colorectal Cancer - Pipeline by Genoscience Pharma, H2 2016 223 Colorectal Cancer - Pipeline by Genzyme Corp, H2 2016 224 Colorectal Cancer - Pipeline by Gilead Sciences Inc, H2 2016 225 Colorectal Cancer - Pipeline by GlaxoSmithKline Plc, H2 2016 226 Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2016 227 Colorectal Cancer - Pipeline by Golden Biotechnology Corp, H2 2016 228 Colorectal Cancer - Pipeline by Green Cross Corp, H2 2016 229 Colorectal Cancer - Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016 230 Colorectal Cancer - Pipeline by Handok Inc, H2 2016 231 Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2016 232 Colorectal Cancer - Pipeline by Heat Biologics Inc, H2 2016 233 Colorectal Cancer - Pipeline by Hemispherx Biopharma Inc, H2 2016 234 Colorectal Cancer - Pipeline by Hutchison MediPharma Ltd, H2 2016 235 Colorectal Cancer - Pipeline by iDD biotech SAS, H2 2016 236 Colorectal Cancer - Pipeline by Ideaya Biosciences Inc, H2 2016 237 Colorectal Cancer - Pipeline by Ignyta Inc, H2 2016 238 Colorectal Cancer - Pipeline by Immodulon Therapeutics Ltd, H2 2016 239 Colorectal Cancer - Pipeline by ImmuneXcite Inc, H2 2016 240 Colorectal Cancer - Pipeline by Immunomedics Inc, H2 2016 241 Colorectal Cancer - Pipeline by Immunovative Therapies Ltd, H2 2016 242 Colorectal Cancer - Pipeline by Incanthera Ltd, H2 2016 243 Colorectal Cancer - Pipeline by Incyte Corp, H2 2016 244 Colorectal Cancer - Pipeline by Innovent Biologics Inc, H2 2016 245 Colorectal Cancer - Pipeline by Inovio Pharmaceuticals Inc, H2 2016 246 Colorectal Cancer - Pipeline by Interprotein Corp, H2 2016 247 Colorectal Cancer - Pipeline by Intezyne Technologies Inc, H2 2016 248 Colorectal Cancer - Pipeline by Ionis Pharmaceuticals Inc, H2 2016 249 Colorectal Cancer - Pipeline by IPD Therapeutics BV, H2 2016 250 Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2016 251 Colorectal Cancer - Pipeline by Jeil Pharmaceutical Co Ltd, H2 2016 252 Colorectal Cancer - Pipeline by JHL Biotech Inc, H2 2016 253 Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2016 254 Colorectal Cancer - Pipeline by Johnson & Johnson, H2 2016 255 Colorectal Cancer - Pipeline by KaloBios Pharmaceuticals Inc, H2 2016 256 Colorectal Cancer - Pipeline by Kancera AB, H2 2016 257 Colorectal Cancer - Pipeline by Karyopharm Therapeutics Inc, H2 2016 258 Colorectal Cancer - Pipeline by Kura Oncology Inc, H2 2016 259 Colorectal Cancer - Pipeline by Laboratorio ELEA SACIF y A, H2 2016 260 Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Ltd, H2 2016 261 Colorectal Cancer - Pipeline by Lion Biotechnologies Inc, H2 2016 262 Colorectal Cancer - Pipeline by LipoMedix Pharmaceutical Inc, H2 2016 263 Colorectal Cancer - Pipeline by Loxo Oncology, Inc., H2 2016 264 Colorectal Cancer - Pipeline by Mabion SA, H2 2016 265 Colorectal Cancer - Pipeline by Mabtech Ltd, H2 2016 266 Colorectal Cancer - Pipeline by mAbxience SA, H2 2016 267 Colorectal Cancer - Pipeline by MacroGenics Inc, H2 2016 268 Colorectal Cancer - Pipeline by Marina Biotech Inc, H2 2016 269 Colorectal Cancer - Pipeline by MediaPharma srl, H2 2016 270 Colorectal Cancer - Pipeline by MedImmune LLC, H2 2016 271 Colorectal Cancer - Pipeline by Medinet Co Ltd, H2 2016 272 Colorectal Cancer - Pipeline by Merck & Co Inc, H2 2016 273 Colorectal Cancer - Pipeline by Merck KGaA, H2 2016 274 Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals Inc, H2 2016 275 Colorectal Cancer - Pipeline by Merus NV, H2 2016 276 Colorectal Cancer - Pipeline by Microlin Bio, Inc., H2 2016 277 Colorectal Cancer - Pipeline by MolMed SpA, H2 2016 278 Colorectal Cancer - Pipeline by Mologen AG, H2 2016 279 Colorectal Cancer - Pipeline by Morphotek Inc, H2 2016 280 Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2016 281 Colorectal Cancer - Pipeline by Mycenax Biotech Inc, H2 2016 282 Colorectal Cancer - Pipeline by Natco Pharma Ltd, H2 2016 283 Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corp, H2 2016 284 Colorectal Cancer - Pipeline by Nektar Therapeutics, H2 2016 285 Colorectal Cancer - Pipeline by Neovacs SA, H2 2016 286 Colorectal Cancer - Pipeline by Nerviano Medical Sciences Srl, H2 2016 287 Colorectal Cancer - Pipeline by Nippon Kayaku Co Ltd, H2 2016 288 Colorectal Cancer - Pipeline by NormOxys Inc, H2 2016 289 Colorectal Cancer - Pipeline by Northwest Biotherapeutics Inc, H2 2016 290 Colorectal Cancer - Pipeline by Novartis AG, H2 2016 291 Colorectal Cancer - Pipeline by Novogen Ltd, H2 2016 292 Colorectal Cancer - Pipeline by Noxxon Pharma AG, H2 2016 293 Colorectal Cancer - Pipeline by NuCana BioMed Ltd, H2 2016 294 Colorectal Cancer - Pipeline by OBI Pharma Inc, H2 2016 295 Colorectal Cancer - Pipeline by Oncobiologics Inc, H2 2016 296 Colorectal Cancer - Pipeline by Oncolytics Biotech Inc, H2 2016 297 Colorectal Cancer - Pipeline by OncoMed Pharmaceuticals Inc, H2 2016 298 Colorectal Cancer - Pipeline by Onconova Therapeutics Inc, H2 2016 299 Colorectal Cancer - Pipeline by Ono Pharmaceutical Co Ltd, H2 2016 300
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
